Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > 57,000 views, THTX YouTube video link below

<< Previous

Bullboard Posts

Next >>

Comment by jfm1330on Sep 27, 2022 11:19am

63 Views

Post# 34989415

RE:57,000 views, THTX YouTube video link below

I still have a hard time believing this guy and his falsehoods are the reason for the little run up. It is clear that he knows nothing about Thera and Trogarzo.

TH1902 wrote: Was curious so I found the video that referenced THTX, here it is, starts around 4:30 point, pitched as a trade on FDA response expected Oct. 3rd

https://www.youtube.com/watch?v=O6tkOY0GTVI